Dr Dipender Gill
Principal & Lead for Integrated Omics
I am the Lead for Integrated Omics in the Health Analytics team at LCP. My background is as a Clinical Pharmacologist and General Internal Physician, with more than 11 years of experience within the National Health Service, a Genetic Epidemiologist with more than 200 publications and an ongoing affiliation at Imperial College London, and as an expert at optimising the integration of human-centric evidence to inform drug development, with more than 3 years of experience in this capacity at the pharmaceutical company Novo Nordisk.
My role at LCP is to lead a multi-disciplinary team focused on leveraging multi-omics data, including genomics, metabolomics, and proteomics, to unravel disease mechanisms, inform drug development efforts, and study the effects of healthcare interventions. My combined expertise in medicine, genetic epidemiology and drug development uniquely positions me as a leading authority on the applications of omics data for generating clinically translatable insights.
I am currently on the Editorial Board of BMJ Medicine, serve as an Editorial Advisor at BMC Medicine, and remain active in research with an H-index of 38, contributing to several international genetic consortia, including the International Stroke Genetics Consortium and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE).
Our latest thinking
How I can help
We apply scientific rigour to evaluate the economic and clinical value of healthcare interventions using both traditional and innovative perspectives and methods.
We understand that developing a comprehensive Real-World Evidence (RWE) strategy is not just a necessity, but a game-changer for life science companies. Leveraging our deep expertise, we help our clients develop holistic strategies that plan for all RWE needs across all stages of the medicine lifecycle.
Our health analytics approach leverages the increasing availability of data and our cutting-edge modelling approaches to put timely actionable data in the hands of key stakeholders.
We integrate a wealth of health and health-related datasets and develop bespoke interactive visualisations to make it accessible and rapid for clients to glean insights across a range of areas.
Multimorbidity, living with two or more conditions is one of the biggest challenges facing patients and health systems today. We leverage real world datasets and innovative approaches to generate evidence that identifies patient groups with the greatest unmet needs in a more holistic manner that reflects the drivers of ill health.